Management Credibility and Data Release

This chapter discusses the recent data release and management credibility issues surrounding a biotech company. There are concerns about the company's competitive advantage and the disclosure of endoscopic improvement numbers. It also mentions the CEO taking a medical leave of absence.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app